2Kantor PF,Lucien A,Kozak R,et al.The antianginal drug trimetazidone shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibititg mitochondrial long-chain 3-ketoa cyl coenzyme A thiolase.Circ Res,2000,86:580-588.
3Lavancy N,Martin J,Rossi A.Anti-ischemic effects of trimetazidine:3 IP-NMR spectroscopy in the isolated rat heart.Arch Intern Pharmacol Ther,1987,1:97-110.
4Renaud JF,Internal Ph.Na+ and Ca2+ regulation by trimetazidine during cardiac cellacidosis.Cardiovasc Drug Ther,1988,1:677-686.
5Guarmieri C,Muscari C.Effect of trimetazidine on mitechondrial function and oxidative damage during reperfusion of ischemic hypertrophied rat myocardium.Pharmacology,1993,46:324-331.
6Boucher FR,Hearse DJ,Opie LH.Effects of trimetazidine on ischaemic contracture in isolated perfused rat hearts.J Cardiovasc Pharmaco,1994,24:45 -49.
7Belcher PR,Drake-Holland AJ,Hynd JW,et al.Effect of trimetazidine on in vivo coronary arterial platelet thrombosis.Cardiovasc Drugs Ther,1993,7(1):149.
8Williams FM,Tanda K,Kus M,et al.Trimetazidine inhibits neutrophil accumulation after myocardial ischaemia and reperfusion in rabbits.J Cardiovasc Pharmacol,1993,22(6):828-833.
